Biocorrx (OTCMKTS:BICX) Announces Earnings Results

Biocorrx (OTCMKTS:BICX) released its quarterly earnings results on Friday. The company reported ($0.03) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.06) by $0.03, Zacks reports.

Biocorrx Stock Up 20.9%

Shares of Biocorrx stock traded up $0.09 during trading hours on Friday, reaching $0.49. 27,821 shares of the stock traded hands, compared to its average volume of 7,777. The company has a 50 day moving average price of $0.37 and a 200 day moving average price of $0.35. The firm has a market capitalization of $14.36 million, a price-to-earnings ratio of -2.60 and a beta of 0.17. Biocorrx has a one year low of $0.20 and a one year high of $1.28.

About Biocorrx

BioCorRx Inc, through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition.